PeptideNerds

Tesofensine

GLP-1 / Weight Loss Research Only moderate evidence Track This Protocol
Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated April 2026

Key Takeaway

Tesofensine is a triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) that reduces appetite through central nervous system pathways different from GLP-1 agonists.

Quick Facts
Type GLP-1 / Weight Loss
FDA Status Research Only
Evidence Level Moderate
Typical Dose 0.25 mg to 0.5 mg daily
Frequency Once daily oral
Key Goals weight-loss, fat-loss

How it works

Inhibits reuptake of serotonin, norepinephrine, and dopamine in the brain, reducing appetite and increasing thermogenesis through different pathways than GLP-1 agonists.

Benefits

  • Oral capsule (no injection)
  • Different mechanism than GLP-1s
  • Can potentially be combined with GLP-1 agonists

Side effects

  • Increased heart rate
  • Dry mouth
  • Insomnia
  • Constipation
  • Mood changes

Dosing protocol

Typical Dose

0.25 mg to 0.5 mg daily

Frequency

Once daily oral

Not FDA-approved. Available through some compounding pharmacies.

Deeper on Tesofensine

Full breakdowns of every part of the Tesofensine research base.

What you will need

Basic supplies for reconstitution and subcutaneous injection.

This page contains affiliate links. Learn more

Get the Tesofensine cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Get the Tesofensine cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Compare Tesofensine

Related peptides

Get the Peptide Starter Kit (free)

Quick-start guide to GLP-1 peptides, dosing basics, and what to ask your doctor.

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.